Jupiter Research Capital (Asia) Ltd’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-23,450
Closed -$1.76M – 873
2026
Q2
$1.76M Buy
+23,450
New +$1.51M 0.2% 106

Other funds holding HAE

Jupiter Research Capital (Asia) Ltd's HAE Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd sold out of Haemonetics (HAE) in Q3 2026, closing a stake of 23,450 shares — an estimated $1.76M sold.

Jupiter Research Capital (Asia) Ltd first reported a position in HAE in Q2 2026 and held it in 1 quarter. The position peaked at $1.76M in Q2 2026. 334 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd reported no remaining Haemonetics position as of Q3 2026 after selling out during the quarter.
  • Jupiter Research Capital (Asia) Ltd sold 23,450 Haemonetics shares in Q3 2026, an estimated $1.76M.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Haemonetics in Q2 2026 and held it in 1 quarter.
  • Jupiter Research Capital (Asia) Ltd's Haemonetics position peaked at $1.76M in Q2 2026.
  • 334 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.